Linnodee was established in 1999 by the late Dr Ernest F Logan OBE and manufacture and research rapid diagnostics primarily for the detection of Leptospirosis in animals and humans.
Using new and trusted technologies Linnodee have developed a range of rapid and reliable tests for both laboratory diagnosis and point-of-care diagnosis of Leptospirosis in animals and humans. Linnodee diagnostics are designed for the specific detection of the disease-causing serovar(s) associated with the target species.
Linnodee Diagnostics play a crucial role in the surveillance and control of Leptospirosis within animals and humans globally.
Linnodee products are used extensively locally, nationally and internationally. Export markets include Spain, Belgium, Germany, Japan, USA, Malaysia and India. The products have been employed in disease prevalence studies conducted in Europe, Japan, USA, Thailand and South America.